North America Neurocognitive Assessment And Rehabilitation Market Size, Share & Trends Analysis Report By Component (Neurorehabilitation Therapy, and Neurocognitive Assessment Testing), By Providers, By Country and Growth Forecast, 2023 - 2030

North America Neurocognitive Assessment And Rehabilitation Market Size, Share & Trends Analysis Report By Component (Neurorehabilitation Therapy, and Neurocognitive Assessment Testing), By Providers, By Country and Growth Forecast, 2023 - 2030


The North America Neurocognitive Assessment And Rehabilitation Market would witness market growth of 7.7% CAGR during the forecast period (2023-2030).

Neurocognitive assessment systematically evaluates an individual's cognitive functions, including memory, attention, language, executive functions, and sensory-perceptual abilities. This process involves a battery of standardized tests and tools designed to measure cognitive performance and identify deviations from the norm. Assessment tools may range from traditional paper-and-pencil tests to cutting-edge neuroimaging techniques, providing a comprehensive picture of an individual's cognitive health. On the other hand, neurocognitive rehabilitation involves therapeutic interventions to improve or restore cognitive functions that have been compromised due to neurological conditions, injuries, or age-related factors.

Moreover, the market is evolving, propelled by advancements in neuroscience, technology, and an increasing awareness of neurological disorders. This burgeoning field focuses on understanding and addressing cognitive impairments through a multidisciplinary approach, encompassing assessments, interventions, and rehabilitation strategies. As they delve into this dynamic landscape, it becomes evident that the intersection of neuroscience and technology unlocks unprecedented opportunities to enhance the understanding of the brain, diagnose cognitive disorders, and implement effective rehabilitation techniques.

The Centers for Disease Control and Prevention estimate that more than one in every seven adults in the United States has CKD, or approximately 35.5 million individuals, or 14%. People aged 65 or older have a higher prevalence of CKD (34%) compared to those aged 45–64 (12%) or 18–44 (6%). Early identification enables timely intervention and the implementation of strategies to address cognitive deficits before they significantly impact daily functioning. As a result, these aspects will boost market growth in the coming years.

The US market dominated the North America Neurocognitive Assessment And Rehabilitation Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $5,691.8 Million by 2030. The Canada market is experiencing a CAGR of 10.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 9.1% during (2023 - 2030).

Based on Component, the market is segmented into Neurorehabilitation Therapy, and Neurocognitive Assessment Testing. Based on Providers, the market is segmented into Rehab Centers, Hospital & Clinics, Homecare Settings, and Physiotherapy Centers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cambridge Cognition Holdings plc, Cognifit, Inc., Cogstate Ltd., Lumos Labs, Inc. (Lumosity), CNS Vital Signs, LLC, Posit Science Corporation, BrainCheck, Inc., Constant Therapy Health, NeuronUP SL and SCHUHFRIED GmbH

Scope of the Study

Market Segments covered in the Report:

By Component
  • Neurorehabilitation Therapy
  • Neurocognitive Assessment Testing
By Providers
  • Rehab Centers
  • Hospital & Clinics
  • Homecare Settings
  • Physiotherapy Centers
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Cambridge Cognition Holdings plc
  • Cognifit, Inc.
  • Cogstate Ltd.
  • Lumos Labs, Inc. (Lumosity)
  • CNS Vital Signs, LLC
  • Posit Science Corporation
  • BrainCheck, Inc.
  • Constant Therapy Health
  • NeuronUP SL
  • SCHUHFRIED GmbH
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Neurocognitive Assessment And Rehabilitation Market, by Component
1.4.2 North America Neurocognitive Assessment And Rehabilitation Market, by Providers
1.4.3 North America Neurocognitive Assessment And Rehabilitation Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Neurocognitive Assessment And Rehabilitation Market by Component
4.1 North America Neurorehabilitation Therapy Market by Country
4.2 North America Neurocognitive Assessment Testing Market by Country
Chapter 5. North America Neurocognitive Assessment And Rehabilitation Market by Providers
5.1 North America Rehab Centers Market by Country
5.2 North America Hospital & Clinics Market by Country
5.3 North America Homecare Settings Market by Country
5.4 North America Physiotherapy Centers Market by Country
Chapter 6. North America Neurocognitive Assessment And Rehabilitation Market by Country
6.1 US Neurocognitive Assessment And Rehabilitation Market
6.1.1 US Neurocognitive Assessment And Rehabilitation Market by Component
6.1.2 US Neurocognitive Assessment And Rehabilitation Market by Providers
6.2 Canada Neurocognitive Assessment And Rehabilitation Market
6.2.1 Canada Neurocognitive Assessment And Rehabilitation Market by Component
6.2.2 Canada Neurocognitive Assessment And Rehabilitation Market by Providers
6.3 Mexico Neurocognitive Assessment And Rehabilitation Market
6.3.1 Mexico Neurocognitive Assessment And Rehabilitation Market by Component
6.3.2 Mexico Neurocognitive Assessment And Rehabilitation Market by Providers
6.4 Rest of North America Neurocognitive Assessment And Rehabilitation Market
6.4.1 Rest of North America Neurocognitive Assessment And Rehabilitation Market by Component
6.4.2 Rest of North America Neurocognitive Assessment And Rehabilitation Market by Providers
Chapter 7. Company Profiles
7.1 Cambridge Cognition Holdings PLC
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.1.5.3 Acquisition and Mergers:
7.1.6 SWOT Analysis
7.2 Cognifit, Inc.
7.2.1 Company Overview
7.3 Cogstate Ltd.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 SWOT Analysis
7.4 Lumos Labs, Inc. (Lumosity)
7.4.1 Company Overview
7.4.2 SWOT Analysis
7.5 CNS Vital Signs, LLC
7.5.1 Company Overview
7.5.2 SWOT Analysis
7.6 Posit Science Corporation
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 BrainCheck, Inc.
7.7.1 Company Overview
7.7.2 SWOT Analysis
7.8 Constant Therapy Health
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Trials and Approvals:
7.8.3 SWOT Analysis
7.9 NeuronUP SL
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. SCHUHFRIED GmbH
7.10.1 Company Overview
7.10.2 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings